ANIP
Ani Pharmaceuticals
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ANIP
- PE Ratio
The PE ratio for Ani Pharmaceuticals stock stands at 19.61 as of Jun 22, 2026. This results from the current EPS of $4.11 and stock price of $80.58.
ANIP PE ratio history
Over the last ten years, the average PE ratio of Ani Pharmaceuticals has been 496.67. The current 19.61 PE ratio is 96% below the historical average. Over the past ten years, ANIP's PE ratio was at its highest in the Jun 2018 quarter at 6,680, with a price of $66.8 and an EPS of $0.01. The Mar 2026 quarter recorded the bottom point at 18.71, with a price of $76.9 and an EPS of $4.11.
Ani Pharmaceuticals PE ratio by year
Maximum annual increase: 429.36% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 22.55 | N/A | $78.94 | $3.5 |
| 2024 | N/A | N/A | $55.28 | -$1.04 |
| 2023 | 64.12 | N/A | $55.14 | $0.86 |
| 2022 | N/A | N/A | $40.23 | -$3.05 |
| 2021 | N/A | N/A | $46.08 | -$3.4 |
| 2020 | N/A | N/A | $29.04 | -$1.88 |
| 2019 | 120.92 | 251.82% | $61.67 | $0.51 |
| 2018 | 34.37 | N/A | $45.02 | $1.31 |
| 2017 | N/A | N/A | $64.45 | -$0.09 |
| 2016 | 178.29 | 429.36% | $60.62 | $0.34 |
| 2015 | 33.68 | 55.85% | $45.13 | $1.34 |
| 2014 | 21.61 | N/A | $56.39 | $2.61 |
| 2013 | N/A | N/A | $20.08 | -$0.92 |
| 2012 | N/A | N/A | $7.38 | -$7.6 |
| 2011 | N/A | N/A | $18.08 | -$18.9 |
Ani Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 18.71 | -17.03% | $76.9 | $4.11 |
| Dec 2025 | 22.55 | -57.91% | $78.94 | $3.5 |
| Sep 2025 | 53.57 | N/A | $91.6 | $1.71 |
| Jun 2025 | N/A | N/A | $65.25 | -$0.75 |
| Mar 2025 | N/A | N/A | $66.95 | -$1.26 |
| Dec 2024 | N/A | N/A | $55.28 | -$1.04 |
| Sep 2024 | N/A | N/A | $59.66 | -$0.55 |
| Jun 2024 | 53.97 | 26.48% | $63.68 | $1.18 |
| Mar 2024 | 42.67 | -33.45% | $69.13 | $1.62 |
| Dec 2023 | 64.12 | -41.47% | $55.14 | $0.86 |
| Sep 2023 | 109.55 | N/A | $58.06 | $0.53 |
| Jun 2023 | N/A | N/A | $53.83 | -$0.48 |
| Mar 2023 | N/A | N/A | $39.72 | -$1.72 |
| Dec 2022 | N/A | N/A | $40.23 | -$3.05 |
| Sep 2022 | N/A | N/A | $32.14 | -$4.63 |
ANIP Price vs fair value
ANIP average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, ANIP's PE ratio is below the 3, 5 and 10-year averages.
PE comparison
With a P/E of 19.61, ANIP is above the industry average but below the Healthcare sector and its peers average. Compared to its Healthcare sector average of 24.1, Ani Pharmaceuticals's P/E is 19% lower.
ANIP PE vs peers
ANIP's PE ratio is lower than its peer stocks NVS and CAH, but it is greater than PFE's. Ani Pharmaceuticals's current PE ratio of 19.61 is below the average of its peers, which is 25.16.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFE Pfizer Inc | 18.89 | $141.06B |
| ANIP Ani Pharmaceuticals Inc | 20.17 | $1.89B |
| NVS Novartis AG | 21.85 | $292.66B |
| TEVA Teva Pharmaceutical Industries Ltd | 24.15 | $38.52B |
| RPRX Royalty Pharma plc | 28.98 | $31.87B |
| CAH Cardinal Health Inc | 34.16 | $52.56B |
| JAZZ Jazz Pharmaceuticals plc | 490.26 | $14.46B |
| CLDX Celldex Therapeutics Inc | N/A | $2.59B |
Frequently asked questions
What is Ani Pharmaceuticals's PE ratio?
ANIP's price to earnings ratio is 19.61 as of Jun 22, 2026.
What is the 3-year average PE ratio for Ani Pharmaceuticals (ANIP)?
The 3-year average PE ratio for ANIP stock is 52.16.
What is the 5-year average PE ratio for Ani Pharmaceuticals (ANIP)?
The 5-year average PE ratio for ANIP stock is 52.16.
What is the highest PE ratio for ANIP?
Over the last ten years, the quarterly PE ratio reached a historic high of 6,680 in the Jun 2018 quarter.
How does the current PE ratio for ANIP compare to its historical average?
ANIP's price to earnings ratio is currently 96% below its 10-year historical average.
How is ANIP's PE ratio calculated (Ani Pharmaceuticals PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 22, 2026), Ani Pharmaceuticals's stock price is $80.58. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $4.11. Therefore, Ani Pharmaceuticals's P/E ratio for today is 19.61. PE RATIO(19.61) = STOCK PRICE($80.58) / TTM EPS($4.11)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.